BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 11580310)

  • 21. Treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
    Fukushima T; Yamamoto M; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M
    Anticancer Res; 1998; 18(5D):3965-70. PubMed ID: 9854511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma.
    Grossman SA; Wharam M; Sheidler V; Kleinberg L; Zeltzman M; Yue N; Piantadosi S
    J Clin Oncol; 1997 Jul; 15(7):2596-603. PubMed ID: 9215830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy of High-Grade Astrocytomas in Adults.
    Puduvalli VK; Hoang N
    Prog Neurol Surg; 2018; 31():116-144. PubMed ID: 29393181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-drug versus single agent chemotherapy for high grade astrocytoma; results of a meta-analysis.
    Huncharek M; Muscat J; Geschwind JF
    Anticancer Res; 1998; 18(6B):4693-7. PubMed ID: 9891542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatments for astrocytic tumors in children: current and emerging strategies.
    Burzynski SR
    Paediatr Drugs; 2006; 8(3):167-78. PubMed ID: 16774296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of high-dose chemotherapy with hemopoietic stem-cell support in the treatment of adult patients with high-grade glioma].
    Linassier C; Destrieux C; Benboubker L; Alcaraz L; Bergemer-Fouquet AM; Jan M; Calais G; Colombat P
    Bull Cancer; 2001 Sep; 88(9):871-6. PubMed ID: 11604360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gliomas in adults: primary non-surgical treatment].
    Poulsen HS
    Ugeskr Laeger; 2006 Nov; 168(47):4082-5. PubMed ID: 17134603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffuse and focal brain stem tumors in childhood: prognostic factors and surgical outcome. Experience in a single institution.
    Sandri A; Sardi N; Genitori L; Giordano F; Peretta P; Basso ME; Bertin D; Mastrodicasa L; Todisco L; Mussa F; Forni M; Ricardi U; Cordero di Montezemolo L; Madon E
    Childs Nerv Syst; 2006 Sep; 22(9):1127-35. PubMed ID: 16568342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there a role for myeloablative chemotherapy with autologous hematopoietic cell rescue in the management of childhood high-grade astrocytomas?
    Massimino M; Cohen KJ; Finlay JL
    Pediatr Blood Cancer; 2010 Apr; 54(4):641-3. PubMed ID: 20146219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Individualized therapy and outcomes of microsurgery, radiotherapy, and chemotherapy for astrocytoma].
    Zhou WN; Chen ZP; You C; Mu YG; Sai K; Zhang JY; Zhang XH; Cheng JJ; Xu HC
    Ai Zheng; 2004 Nov; 23(11 Suppl):1555-60. PubMed ID: 15566679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current trends in chemotherapy for metastatic nonseminomatous testicular germ cell tumors.
    Bokemeyer C
    Oncology; 1998; 55(3):177-88. PubMed ID: 9560052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel therapies for malignant gliomas: a local affair?
    Rainov NG; Söling A; Heidecke V
    Neurosurg Focus; 2006 Apr; 20(4):E9. PubMed ID: 16709040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Editorial: what is new in the treatment of gliomas?
    Omuro AM; Delattre JY
    Curr Opin Neurol; 2007 Dec; 20(6):704-7. PubMed ID: 17992093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience.
    Turner CD; Gururangan S; Eastwood J; Bottom K; Watral M; Beason R; McLendon RE; Friedman AH; Tourt-Uhlig S; Miller LL; Friedman HS
    Neuro Oncol; 2002 Apr; 4(2):102-8. PubMed ID: 11916501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Resent advances in chemotherapy for malignant brain tumors].
    Shibui S
    Gan To Kagaku Ryoho; 2005 Apr; 32(4):442-7. PubMed ID: 15853207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of newly diagnosed diffuse brain stem gliomas in children: in search of the holy grail.
    Korones DN
    Expert Rev Anticancer Ther; 2007 May; 7(5):663-74. PubMed ID: 17492930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenomics, informatics, and individual drug therapy in psychiatry: past, present and future.
    Preskorn SH
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):85-94. PubMed ID: 16785276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.